The information on this page is not intended as medical advice or clinician guidance. Please help us be more inclusive of fact-based resources that would add to the quality of this page by sending to: editor@globalbiodefense.com

Pfizer and BioNTech Submit COVID-19 Vaccine for Emergency Use Approval in U.S.

Pfizer and BioNTech Submit COVID-19 Vaccine for Emergency Use Approval in U.S.

Pfizer Inc. and BioNTech SE announced they will submit a request today to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of their mRNA…

Lawmakers Press HSS for Information on Remdesivir Pricing Negotiations with Gilead

Lawmakers Press HSS for Information on Remdesivir Pricing Negotiations with Gilead

Last month, the Food and Drug Administration (FDA) gave its first full approval for a COVID-19 therapeutic to Gilead Sciences’ remdesivir, an antiviral drug that…

NIAID Looks Ahead to Pan-Coronavirus Vaccine Candidates

NIAID Looks Ahead to Pan-Coronavirus Vaccine Candidates

With multiple promising SARS-CoV-2 vaccine candidates now under development, the National Institute of Allergy and Infectious Diseases (NIAID) is looking ahead to potential pan-coronavirus (pan-CoV)…

Naval Research Lab Evaluates Ultraviolet Sources Against SARS-CoV-2

Naval Research Lab Evaluates Ultraviolet Sources Against SARS-CoV-2

The Navy is investigating commercial ultraviolet (UV) technologies for viral disinfection to combat COVID-19 for their personnel both on land and at sea. U.S. Naval…

New Understanding of Neuropilin-1 Protein Could Speed Pandemic Vaccine Research

New Understanding of Neuropilin-1 Protein Could Speed Pandemic Vaccine Research

When it comes to how the coronavirus invades a cell, it takes three to tango. The dance began with the ACE2 receptor, a protein on…

Meet Ruby the Supercomputer: Now in Service for COVID-19 and Nuclear Security Research

Meet Ruby the Supercomputer: Now in Service for COVID-19 and Nuclear Security Research

Lawrence Livermore National Laboratory (LLNL), along with partners Intel, Supermicro and Cornelis Networks, have deployed “Ruby,” a high performance computing (HPC) cluster that will perform functions…

View All Featured News



HEADLINE NEWS

Biodefense Headlines – 22 November 2020

Biodefense Headlines – 22 November 2020

News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include the timeline for emergency use authorization of COVID-19 vaccines;…

Biodefense Headlines – 8 November 2020

Biodefense Headlines – 8 November 2020

News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include COVID-19 surveillance data systems; pandemic impact on measles, polio…

Biodefense Headlines – 2 November 2020

Biodefense Headlines – 2 November 2020

News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include partnering with schools for pandemic flu preparedness; validation analysis…

View All Headline News


RESEARCH HIGHLIGHTS

Persons Evaluated for 2019 Novel Coronavirus — United States, January 2020

CDC Morbidity and Mortality Weekly Report (MMWR) On January 17, CDC and the U.S. Department of Homeland Security’s Customs and Border Protection began health screenings at U.S.…

Bats’ Fierce Immune Systems Drive Viruses To Higher Virulence, Making Them Deadlier in Humans

A new University of California, Berkeley, study finds that bats’ fierce immune response to viruses could drive viruses to replicate faster, so that when they jump to…

Steroids Could Do More Harm Than Good in Treating Coronavirus

Steroids should be avoided in the treatment of the current novel coronavirus, experts have advised. A commentary article published in The Lancet concludes that, based on evidence from previous…

A Pneumonia Outbreak Associated with a New Coronavirus of Probable Bat Origin

NOTE: The following paper (.pdf) is undergoing accelerated peer-review. Abstract follows: Since the SARS outbreak 18 years ago, a large number of severe acute respiratory syndrome-related coronaviruses…

Coronavirus and Brexit: UK Must Act Quickly Before Being Shut out of Europe’s Health Protection System

The threat posed by 2019-nCoV and the fragmentation of existing health protection systems caused by Brexit call for urgent assessment of cross Europe cooperation, say Mark Flear…

View All Research Journal Highlights

JOURNAL HUBS

“We call on researchers, journals and funders to ensure that research findings and data relevant to this outbreak are shared rapidly and openly to inform the public health response and help save lives.” – Wellcome Trust

NEJM Novel Coronavirus

JAMA Network 2019-nCoV

The Lancet 2019-nCoV Resource Center

Springer Nature Novel Coronavirus Articles

The BMJ Coronavirus Free Online Resources

Elsevier Novel Coronavirus Information Center

BioRxiv Preprint Server *(Caution: information not yet peer-reviewed)

ASM Journal Network Coronavirus Articles American Society for Microbiology

RSTMH Coronavirus Collection


FUNDING | CONTRACTS | GRANTS


Sign up to receive weekly insights from Global Biodefense


INDUSTRY NEWSWIRE

Novartis to Start Large, Randomized Trial of Hydroxychloroquine in Hospitalized COVID-19 Patients

Novartis has reached an agreement with the US Food and Drug Administration (FDA) to proceed with a Phase III clinical trial with approximately 440 patients to evaluate…

IDEXX Makes Test for COVID-19 Available to Veterinarians Amid Rare Cases of Human-to-Pet Transmission

Understanding of COVID-19 and its effects on animal and human health is evolving rapidly. Leading health authorities and IDEXX veterinarians agree transmission of the SARS-CoV-2 virus is…

Alexion to Initiate Phase 3 Study of Rare Blood-Disorder Drug in Severe COVID-19 Patients

Alexion Pharmaceuticals Inc. announced today it would start a late-stage study of its rare blood-disorder drug, Ultomiris, in COVID-19 patients hospitalized with severe pneumonia or acute respiratory…

BARDA and Hememics Collaborate to Develop Rapid Diagnostic to Identify SARS-CoV-2

BARDA is collaborating with Hememics Biotechnologies, Inc. on the development of a rapid, Bluetooth-connected SARS-CoV-2 diagnostic test. The test is being designed to detect SARS-CoV-2 antigen from…

BARDA and Sanofi Prepare for Studies of COVID-19 Vaccine

BARDA and Sanofi Pasteur, the vaccines global business unit of Sanofi, are expanding their collaboration to develop a SARS-CoV-2 vaccine. The previously announced research for a COVID-19…

View All Industry Newswires


STATE RESOURCES

Arkansas

Arkansas Department of Health

Arkansas Public Health Laboratory

Kentucky

Kentucky Division of Laboratory Service

State Health Officials Actively Monitoring for 2019 Novel Coronavirus 1/29 DPH

District of Columbia
American Samoa